Skip to main content

JANE STREET GROUP, LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1595888 NEW YORK, NY

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$490,366
-$3,718,206 QoQ
Shares Held
61,915
-91.5% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Derivatives in XERS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$99,792
PutShares
12,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $557,642,679 across 56 Drug Manufacturers - Specialty & Generic names. XERS ranks #30 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $490,366 61,915
2026-06-30 $99,792 12,600
2026-03-31 $4,208,572 725,616
2026-03-31 $107,300 18,500
2025-12-31 $102,835 13,100
2025-12-31 $1,395,902 177,822
2025-09-30 $306,878 37,700
2025-09-30 $7,437,989 913,758
2025-06-30 $85,928 18,400
2025-06-30 $145,539 31,165
2025-03-31 $4,503,017 820,222
2025-03-31 $71,919 13,100
2024-12-31 $1,038,170 306,245
2024-09-30 $908,464 318,760
2024-06-30 $782,081 347,592
2024-03-31 $508,206 229,958
2023-12-31 $525,421 223,584
2023-09-30 $267,103 143,604
2023-06-30 $331,207 126,415
2023-03-31 $221,389 135,822
2022-12-31 $241,476 181,562
2022-09-30 $183,452 117,598
2022-06-30 $410,095 266,296
2022-03-31 $1,184,970 462,879
2022-03-31 $222,208 86,800
2022-03-31 $26,368 10,300
2021-12-31 $332,290 113,410
2021-12-31 $67,683 23,100
2021-12-31 $565,490 193,000